This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Major Depressive Disorder
and you are
between 50 and 90
years old
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

Patients with an episode of depression in late life prescribed mirtazapine recruited from a clinical sample will be monitored for weight and receive a blood test during their usual course of treatment to determine polymorphisms in a specific gene (LEPR) thought to affect weight gain.

Provided treatments

  • Drug: Mirtazapine
Tris trial is registered with FDA with number: NCT01601002. The sponsor of the trial is Lawson Health Research Institute and it is looking for 19 volunteers for the current phase.
Official trial title:
Does LEPR Polymorphism Predict Variability in Weight Gain Induced by Mirtazapine in the Treatment of Late Life Depression?